Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/THKzX2Ygo6o   This question continues to pop up, and now we have a randomized, multicenter study to provide a definitive answer.    Collaborators at Duke, Vanderbilt, Baylor, Temple, the University of Kansas, and the Universities of Florida and South Florida studied 1360 health care workers during the pre-vaccine era between April and November, 2020.  A group of 683 participants were randomly chosen to receive a month of HCQ and 676 were selected to receive a placebo.  Each participant was studied for any side effects from the HCQ or placebo, and the chief outcome measure was the development of a CoVid infection as authenticated by a positive PCR test.   When the numbers were tallied, there was good news and bad news associated with the HCQ therapy.  The good news:  those receiving it compared to an innocuous placebo suffered no increase in reported adverse effects.  The bad news: the HCQ does not significantly reduce the risk of CoVid infection.   https://www.medrxiv.org/content